Outcomes and toxicities of re-irradiation for prostate cancer: A systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

被引:22
作者
Munoz, Fernando [1 ]
Fiorica, Francesco [2 ]
Caravatta, Luciana [3 ]
Rosa, Consuelo [3 ]
Ferella, Letizia [1 ]
Boldrini, Luca [4 ]
Fionda, Bruno [4 ]
Alitto, Anna Rita [4 ]
Nardangeli, Alessia [4 ]
Dionisi, Francesco [5 ]
Arcangeli, Stefano [6 ,7 ]
Di Marzo, Alessandro [8 ]
Pontoriero, Antonio [9 ]
Donato, Vittorio [10 ]
Massaccesi, Mariangela [4 ]
机构
[1] Parini Hosp, Radiotherapy Unit, Viale Ginevra 3, I-11100 Aosta, Italy
[2] State Hosp Mater Salutis AULSS 9, Dept Radiat Oncol & Nucl Med, Via Carlo Gianella 1, I-37045 Legnago, VR, Italy
[3] Univ G dAnnunzio, SS Annunziata Hosp, Radiat Oncol Unit, Via Vestini, I-66100 Chieti, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Dept Radiol Radiotherapy & Hematol Sci, Via Pineta Sacchetti 217, I-00168 Rome, Italy
[5] APSS, Proton Therapy Unit, Dept Oncol, Via Alcide Degasperi 79, I-38123 Trento, Italy
[6] Policlin S Gerardo, Dept Radiat Oncol, Via Sansovino 4, I-20133 Milan, Italy
[7] Univ Milano Bicocca, Via Sansovino 4, I-20133 Milan, Italy
[8] S Maria Hosp, Radiotherapy Oncol Ctr, Viale Tristano Joannuccio, I-05100 Terni, Italy
[9] Univ Hosp G Martino, Dept Image Diagnost, Operat Unit Radiat Oncol, Messina, Italy
[10] Azienda Osped San Camillo Forlanini, Radiat Oncol, Circonvallaz Gianicolense 87, I-00152 Rome, Italy
关键词
Cumulative dose; Outcomes; Prostate cancer; Re-irradiation; Toxicity; DOSE-RATE BRACHYTHERAPY; BEAM RADIATION-THERAPY; SALVAGE BRACHYTHERAPY; RECURRENCE; FAILURE;
D O I
10.1016/j.ctrv.2021.102176
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The best therapeutic approach for local relapses of previously irradiated prostate cancer (PC) is still not defined. Re-irradiation (Re-I) could offer a chance of cure for highly selected patients, although high quality evidences are lacking. The aim of our study is to provide a literature review on efficacy and safety of Re-I. Methods: Only studies where Re-I field overlaps with previous radiotherapy were considered. To determine 2 and 4 years overall mortality (OM), 2 and 4 years biochemical failure (BF) and pooled acute and late G 0.001). The pooled result of G 0.001). One hundred and three G 3 late adverse events were reported, with a pooled result of G > 3 late toxicity of 8.7% (95%CI: 5.8?13%, P < 0.001). Conclusions: Re-I of local failures from PC showed promising OM and biochemical control rates with a safe toxicity profile.
引用
收藏
页数:10
相关论文
共 72 条
  • [31] Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report
    Janoray, G.
    Reynaud-Bougnoux, A.
    Ruffier-Loubiere, A.
    Bernadou, G.
    Pointreau, Y.
    Calais, G.
    [J]. CANCER RADIOTHERAPIE, 2016, 20 (04): : 275 - 281
  • [32] Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)
    Jereczek-Fossa, Barbara Alicja
    Rojas, Damaris Patricia
    Zerini, Dario
    Fodor, Cristiana
    Viola, Anna
    Fanetti, Giuseppe
    Volpe, Stefania
    Luraschi, Rosa
    Bazani, Alessia
    Rondi, Elena
    Cattani, Federica
    Vavassori, Andrea
    Garibaldi, Cristina
    Alessi, Sarah
    Pricolo, Paola
    Petralia, Giuseppe
    Cozzi, Gabriele
    De Cobelli, Ottavio
    Musi, Gennaro
    Orecchia, Roberto
    Marvaso, Giulia
    Ciardo, Delia
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1094)
  • [33] JIM NR, 2015, BRACHYTHERAPY, V14, P342, DOI DOI 10.1016/J.BRACHY.2015.01.002
  • [34] Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results
    Jo, Yoshimasa
    Fujii, Tomohiro
    Hara, Ryoei
    Yokoyama, Teruhiko
    Miyaji, Yoshiyuki
    Yoden, Eisaku
    Hiratsuka, Junichi
    Nagai, Atsushi
    [J]. BJU INTERNATIONAL, 2012, 109 (06) : 835 - 839
  • [35] JOHN ML, 2016, TECHNOL CANCER RES T, V2016, P1, DOI DOI 10.1155/2016/9561494
  • [36] JONATHAN O, 2019, FRONT ONCOL, V9, DOI DOI 10.3389/FONC.2019.00071
  • [37] Two-sided confidence intervals for the single proportion: comparison of seven methods
    Julious, SA
    [J]. STATISTICS IN MEDICINE, 2005, 24 (21) : 3383 - 3384
  • [38] A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study
    Kaljouw, Emmie
    Pieters, Bradley R.
    Kovacs, Gyoergy
    Hoskin, Peter J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 118 (01) : 122 - 130
  • [39] Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy
    Kimura, Masaki
    Mouraviev, Vladimir
    Tsivian, Matvey
    Mayes, Janice M.
    Satoh, Takefumi
    Polascik, Thomas J.
    [J]. BJU INTERNATIONAL, 2010, 105 (02) : 191 - 201
  • [40] Magnetic resonance imaging-based salvage brachytherapy: Moving toward a focal paradigm
    Kollmeier, Marisa A.
    Zelefsky, Michael
    McBride, Sean
    [J]. BRACHYTHERAPY, 2017, 16 (04) : 770 - 777